Clinical features of cobimetinib (COBI)–associated serous retinopathy (SR) in BRAF-mutated melanoma patients (pts) treated in the coBRIM study

Authors :: Susan Eng
Jean-Jacques Grob
Jessie J. Hsu
Nicholas Choong
Grant A. McArthur
Antoni Ribas
Alfredo Venosa
Lorenza Di Guardo
James Larkin
Luis de la Cruz-Merino
Giulio Barteselli
Brigitte Dréno
Source :: Journal of Clinical Oncology. 33:9033-9033
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.
Abstract: 9033 Background: Various ocular adverse events (AE) have been described with targeted agents. MEK inhibitors (MEKi) are associated with SR. We describe the clinical features of SR observed with COB...

Subjects :: Oncology
Cobimetinib
Cancer Research
medicine.medical_specialty
Pathology
business.industry
Melanoma
medicine.disease
chemistry.chemical_compound
Serous fluid
chemistry
Internal medicine
medicine
business
Adverse effect
Retinopathy

Full Text Access

Tools